During the past decade, Spring Clinical Research conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spring Clinical Research" #1 collaborator was "Bill and Melinda Gates Foundation" with 1 trials as a collaborator, "DACIMA Software" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "The Government of Quebec" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Spring Clinical Research" are "Cardiovascular Disease" (2 trials) and "Corona Virus Infection" (1 trials). Many other conditions were trialed in "Spring Clinical Research" in a lesser frequency.

Most popular intervention types in "Spring Clinical Research" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Colchicine" (1 trials) and "Placebo oral tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spring Clinical Research" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Spring Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Spring Clinical Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Spring Clinical Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".